Thursday, June 22, 2017


More Story

Tourbillon's Karp says Sarepta shares could surge 200 percent

LAS VEGAS (Reuters) - Hedge fund manager Jason Karp on Thursday said that shares of Sarepta Therapeutics Inc could...